All Photos(1)



Sphinganine-1-Phosphate (d20:0)

Avanti Polar Lipids 860675P, powder

D-erythro-sphinganine-1-phosphate (C20 base)
Empirical Formula (Hill Notation):
CAS Number:
Molecular Weight:




pkg of 1 × 1 mg (860675P-1mg)


Avanti Polar Lipids 860675P

shipped in

dry ice

storage temp.


SMILES string


General description

Sphinganine-1-Phosphate is a phosphorylated derivative of C20 base sphinganine.

Biochem/physiol Actions

Exogenous sphinganine-1-phosphate activates sphingosine-1-phosphate receptor 1 (S1P1). It exhibits protective effects against hepatic and renal ischemia and reperfusion (IR). Sphingosine-1 phosphate and sphinganine-1-phosphate are bioactive lipid mediators. Sphinganine-1-phosphate acts opposite to sphingosine-1 phosphate activities. Increased concentration of sphinganine-1-phosphate acts as a potential biomarker for fumonisin exposure and toxicity in mice.


5 mL Amber Glass Screw Cap Vial (860675P-1mg)

Storage Class Code

13 - Non Combustible Solids



Certificate of Analysis

Enter Lot Number to search for Certificate of Analysis (COA).

Certificate of Origin

Enter Lot Number to search for Certificate of Origin (COO).

More Documents

Quotes and Ordering

Dong-Hyun Kim et al.
Journal of toxicology and environmental health. Part A, 69(23), 2071-2082 (2006-10-25)
Fumonisins are specific inhibitors of ceramide synthase in sphingolipid metabolism. An alteration in sphingolipid metabolism as a result of fumonisin B1 (FB1) exposure is related to cell death, and sphinganine/sphingosine ratio has been used as an indicator of fumonisin exposure
Shizhong Bu et al.
Arthritis and rheumatism, 62(7), 2117-2126 (2010-03-24)
Previous studies have revealed a phosphatase and tensin homolog (PTEN)-dependent interaction between the sphingolipid agonist dihydrosphingosine 1-phosphate (dhS1P) and the transforming growth factor beta/Smad3 signaling pathway. This study was undertaken to examine responses of systemic sclerosis (SSc) fibroblasts to sphingosine
Sang Won Park et al.
Laboratory investigation; a journal of technical methods and pathology, 90(8), 1209-1224 (2010-05-12)
Liver failure due to ischemia and reperfusion (IR) and subsequent acute kidney injury are significant clinical problems. We showed previously that liver IR selectively reduced plasma sphinganine-1-phosphate levels without affecting sphingosine-1-phosphate (S1P) levels. Furthermore, exogenous sphinganine-1-phosphate protected against both liver

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service